These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9149373)

  • 21. A model for human cytochrome P450 2D6 based on homology modeling and NMR studies of substrate binding.
    Modi S; Paine MJ; Sutcliffe MJ; Lian LY; Primrose WU; Wolf CR; Roberts GC
    Biochemistry; 1996 Apr; 35(14):4540-50. PubMed ID: 8605204
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression, purification, and characterization of mouse CYP2d22.
    Yu AM; Haining RL
    Drug Metab Dispos; 2006 Jul; 34(7):1167-74. PubMed ID: 16595712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular modelling of the human cytochrome P450 isoform CYP2A6 and investigations of CYP2A substrate selectivity.
    Lewis DF; Dickins M; Lake BG; Eddershaw PJ; Tarbit MH; Goldfarb PS
    Toxicology; 1999 Mar; 133(1):1-33. PubMed ID: 10413191
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Theoretical investigation of substrate specificity for cytochromes P450 IA2, P450 IID6 and P450 IIIA4.
    De Rienzo F; Fanelli F; Menziani MC; De Benedetti PG
    J Comput Aided Mol Des; 2000 Jan; 14(1):93-116. PubMed ID: 10702928
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Essential requirements for substrate binding affinity and selectivity toward human CYP2 family enzymes.
    Lewis DF
    Arch Biochem Biophys; 2003 Jan; 409(1):32-44. PubMed ID: 12464242
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Homology modelling of human CYP2 family enzymes based on the CYP2C5 crystal structure.
    Lewis DF
    Xenobiotica; 2002 Apr; 32(4):305-23. PubMed ID: 12028664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A preliminary 3D model for cytochrome P450 2D6 constructed by homology model building.
    Koymans LM; Vermeulen NP; Baarslag A; Donné-Op den Kelder GM
    J Comput Aided Mol Des; 1993 Jun; 7(3):281-9. PubMed ID: 8377025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of the cytochrome P450 enzymes involved in the in vitro metabolism of dolasetron. Comparison with other indole-containing 5-HT3 antagonists.
    Sanwald P; David M; Dow J
    Drug Metab Dispos; 1996 May; 24(5):602-9. PubMed ID: 8723743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Competition between cytochrome P-450 isozymes for NADPH-cytochrome P-450 oxidoreductase affects drug metabolism.
    Li DN; Pritchard MP; Hanlon SP; Burchell B; Wolf CR; Friedberg T
    J Pharmacol Exp Ther; 1999 May; 289(2):661-7. PubMed ID: 10215637
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of critical residues in novel drug metabolizing mutants of cytochrome P450 BM3 using random mutagenesis.
    van Vugt-Lussenburg BM; Stjernschantz E; Lastdrager J; Oostenbrink C; Vermeulen NP; Commandeur JN
    J Med Chem; 2007 Feb; 50(3):455-61. PubMed ID: 17266197
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA haplotype-dependent differences in the amino acid sequence of debrisoquine 4-hydroxylase (CYP2D6): evidence for two major allozymes in extensive metabolisers.
    Panserat S; Mura C; Gérard N; Vincent-Viry M; Galteau MM; Jacqz-Aigrain E; Krishnamoorthy R
    Hum Genet; 1994 Oct; 94(4):401-6. PubMed ID: 7927337
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flavocytochrome P450 BM3 substrate selectivity and electron transfer in a model cytochrome P450.
    Munro AW; Noble MA; Ost TW; Green AJ; McLean KJ; Robledo L; Miles CS; Murdoch J; Chapman SK
    Subcell Biochem; 2000; 35():297-315. PubMed ID: 11192726
    [No Abstract]   [Full Text] [Related]  

  • 33. New insights into the structural characteristics and functional relevance of the human cytochrome P450 2D6 enzyme.
    Wang B; Yang LP; Zhang XZ; Huang SQ; Bartlam M; Zhou SF
    Drug Metab Rev; 2009; 41(4):573-643. PubMed ID: 19645588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Three-dimensional models of human and other mammalian microsomal P450s constructed from an alignment with P450102 (P450bm3).
    Lewis DF
    Xenobiotica; 1995 Apr; 25(4):333-66. PubMed ID: 7645302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Site-Directed Mutagenesis of Cytochrome P450 2D6 and 2C19 Enzymes: Expression and Spectral Characterization of Naturally Occurring Allelic Variants.
    Dong AN; Pan Y; Palanisamy UD; Yiap BC; Ahemad N; Ong CE
    Appl Biochem Biotechnol; 2018 Sep; 186(1):132-144. PubMed ID: 29524040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Functional characterization of a first avian cytochrome P450 of the CYP2D subfamily (CYP2D49).
    Cai H; Jiang J; Yang Q; Chen Q; Deng Y
    PLoS One; 2012; 7(6):e38395. PubMed ID: 22675558
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CYP2D44 polymorphisms in cynomolgus and rhesus macaques.
    Uno Y; Uehara S; Kohara S; Osada N; Murayama N; Yamazaki H
    Mol Biol Rep; 2015 Jul; 42(7):1149-55. PubMed ID: 25682269
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A three-dimensional molecular template for substrates of human cytochrome P450 involved in debrisoquine 4-hydroxylation.
    Islam SA; Wolf CR; Lennard MS; Sternberg MJ
    Carcinogenesis; 1991 Dec; 12(12):2211-9. PubMed ID: 1747920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular modeling of human cytochrome P450-substrate interactions.
    Lewis DF
    Drug Metab Rev; 2002; 34(1-2):55-67. PubMed ID: 11996012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Progress in cytochrome P450 active site modeling.
    Kemp CA; Maréchal JD; Sutcliffe MJ
    Arch Biochem Biophys; 2005 Jan; 433(2):361-8. PubMed ID: 15581592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.